by Raynovich Rod | Dec 22, 2017 | Biopharmaceuticals
Biotech Bounce Ignited By Roche (RHHBY) Buy of Ignyta (RXDX) NASDAQ Flat at 6953 Healthcare sector weak down 0.43%. as of 1 PM EST Trading Biotech stocks escaped the doldrums today ignited by Roche (RHHBY) acquisition of Ignyta, Inc. (RXDX) for $1.7B in an all cash...
by Raynovich Rod | Dec 20, 2017 | 2024 Rayno Tools and Diagnostics Portfolio, Biopharmaceuticals, Clinical Diagnostics and Tools
Clinical Diagnostics and Tools: Big Winners Are In Genomics and Personalized Medicine Slower growth in routine clinical diagnostics, tools are favored. Hologic has a unique business model for women’s health and diagnostics. Gene sequencing is important for...
by Raynovich Rod | Dec 14, 2017 | Biopharmaceuticals
Update 12/18 Market Rockets to Records But Biotechs Left Behind Ebullience reigned today stoked by tax cuts around the corner. Although many talking heads have said that the tax cuts are “baked in” it seems that a new view has emerged that equities still...
by Raynovich Rod | Dec 7, 2017 | Biopharmaceuticals
Update 12/12/17 Biotech Rally Stalls at Resistance Celgene (CELG) holds $109. Mid-caps red especially INCY PTLA RDUS. Mixed market on low volume. Alexion (ALXN) trying to bounce. =============== Update 12/10/17 Can the biotech rally continue this week with ASH news?...
by Raynovich Rod | Dec 6, 2017 | Weather//Ski Reports-Western US
2018 LaNina Delivers March Storms-Blocking High Pressure Gone! This NOAA site called the change in February and predicts more cold and wet weather ahead. Mammoth Mountain Expects Big Storms in March-Season Has Been Saved! Snowmaking and Grooming Kept Skiing Good in...
